BindingDB logo
myBDB logout

11 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
8809160 132 Design, synthesis, and evaluation of 2 beta-alkenyl penam sulfone acids as inhibitors of beta-lactamases.EBI F. Hoffmann-La Roche
21676616 15 Side chain SAR of bicyclicß-lactamase inhibitors (BLIs). 2. N-Alkylated and open chain analogs of MK-8712.EBI Merck Research Labs
21664132 47 Thiophenyl oxime-derived phosphonates as nano-molar class C beta-lactamase inhibitors reducing MIC of imipenem against Pseudomonas aeruginosa and Acinetobacter baumannii.EBI Merck
20921316 10 Mechanistic studies of the inactivation of TEM-1 and P99 by NXL104, a novel non-beta-lactam beta-lactamase inhibitor.EBI Novexel
20299220 4 4,7-Dichloro benzothien-2-yl sulfonylaminomethyl boronic acid: first boronic acid-derived beta-lactamase inhibitor with class A, C, and D activity.EBI Merck
20044254 14 Side chain SAR of bicyclic beta-lactamase inhibitors (BLIs). 1. Discovery of a class C BLI for combination with imipinem.EBI Merck Research Labs
9767633 76 Structure-based design of beta-lactamase inhibitors. 1. Synthesis and evaluation of bridged monobactams.EBI F. Hoffmann-La Roche
8064298 9 SB-202742, a novel beta-lactamase inhibitor isolated from Spondias mombin.EBI Smithkline Beecham Pharmaceuticals
8421286 44 Inhibitors of protein kinase C. 3. Potent and highly selective bisindolylmaleimides by conformational restriction.BDB Roche Products